Haemonetics Corp. (HAE)
70.37
+0.26
(+0.37%)
USD |
NYSE |
Jan 22, 13:43
Haemonetics EPS Diluted (Quarterly): 0.8116 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| Solventum Corp. | 7.218 |
| DexCom, Inc. | 0.7035 |
| Masimo Corp. | -1.859 |
| UFP Technologies, Inc. | 2.106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.68M |
| Revenue (Quarterly) | 327.32M |
| Total Expenses (Quarterly) | 288.63M |
| Enterprise Value | 4.210B |
| Gross Profit Margin (Quarterly) | 56.04% |
| Profit Margin (Quarterly) | 11.82% |
| Earnings Yield | 4.87% |
| Operating Earnings Yield | 6.85% |
| Normalized Earnings Yield | 4.881 |